|
traditional chinese medicine |
9 |
|
chinese medicine |
8 |
|
diabetic retinopathy |
8 |
|
oxidative stress |
8 |
|
berberine |
7 |
|
gut microbiota |
7 |
|
hepatocellular carcinoma |
7 |
|
hepatotoxicity |
7 |
|
herbal medicine |
7 |
|
cachexia |
6 |
|
cancer diagnosis |
6 |
|
cancer metastasis |
6 |
|
covid-19 |
6 |
|
diagnosis |
6 |
|
gardenia |
6 |
|
iridoid glycosides |
6 |
|
iridoids |
6 |
|
natural products |
6 |
|
obesity |
6 |
|
prognosis |
6 |
|
tumor microenvironment |
6 |
|
type 2 diabetes mellitus |
6 |
|
cancer |
5 |
|
cytokine storm |
5 |
|
immune response |
5 |
|
network pharmacology |
5 |
|
non-alcoholic fatty liver disease |
5 |
|
organ protection |
5 |
|
virus infection |
5 |
|
akt/mtor |
4 |
|
beige cell |
4 |
|
diabetic kidney disease |
4 |
|
diabetic nephropathy |
4 |
|
endoplasmic reticulum stress |
4 |
|
he-ying-qing-re formula |
4 |
|
hif-1α |
4 |
|
inflammation |
4 |
|
insulin |
4 |
|
leptin |
4 |
|
retinal degeneration |
4 |
|
rgc apoptosis |
4 |
|
signaling pathway |
4 |
|
tumor angiogenesis |
4 |
|
vegf |
4 |
|
white adipocyte |
4 |
|
5-fluorouracil |
3 |
|
acsl4 |
3 |
|
akkermansia muciniphila |
3 |
|
alternative therapy |
3 |
|
alzheimer’s disease |
3 |
|
amyloid-beta precursor protein |
3 |
|
anti-tumor immunity |
3 |
|
artificial intelligence |
3 |
|
bioinformatics analysis |
3 |
|
biomarkers |
3 |
|
bl02 |
3 |
|
blended learning |
3 |
|
botanical drug pairs |
3 |
|
cancer drug resistance |
3 |
|
cancer drug sensitivity |
3 |
|
cancer prognosis |
3 |
|
cancer progression |
3 |
|
cancer stem cells |
3 |
|
cancer surveillance |
3 |
|
cancer therapy |
3 |
|
cancer treatment |
3 |
|
cancer-related fatigue |
3 |
|
case study |
3 |
|
cell-free dna |
3 |
|
chemotherapy-induced diarrhea |
3 |
|
chinese herbal |
3 |
|
chinese herbal antioxidants |
3 |
|
chinese herbal medicine formula |
3 |
|
circrnas |
3 |
|
circulating tumor cell (ctc) |
3 |
|
circulating tumor cells |
3 |
|
circulating tumor dna |
3 |
|
clinical trials |
3 |
|
colorectal cancer |
3 |
|
crgs |
3 |
|
crispr-cas9 |
3 |
|
crispr/cas9 screens |
3 |
|
cuproptosis |
3 |
|
cxcl2 |
3 |
|
diabetes |
3 |
|
diabetes mellitus |
3 |
|
diabetic complications |
3 |
|
dili |
3 |
|
disease detection |
3 |
|
disease progression |
3 |
|
drug discovery |
3 |
|
drug discovery and development |
3 |
|
drug reaction |
3 |
|
drug response |
3 |
|
drug-induced liver injury |
3 |
|
e-learning |
3 |
|
early detection |
3 |
|
efficacy |
3 |
|
egfr |
3 |
|
endothelial cells |
3 |
|
endothelial dysfunctions |
3 |
|
epigallocatechin gallate |
3 |
|
ets1 |
3 |
|
exosomal lncrnas |
3 |
|
exosome |
3 |
|
experimental models |
3 |
|
fak |
3 |
|
fak inhibitors |
3 |
|
fatty acid oxidation |
3 |
|
fatty acids |
3 |
|
fatty liver |
3 |
|
ferroptosis |
3 |
|
fibrosis |
3 |
|
field trip |
3 |
|
flavonoid |
3 |
|
gallic acid |
3 |
|
gc |
3 |
|
gegen qinlian decoction |
3 |
|
gentiana rhodantha |
3 |
|
gerbera anandria |
3 |
|
gout |
3 |
|
gpc2 |
3 |
|
green tea |
3 |
|
gut microbiome |
3 |
|
gut–liver axis |
3 |
|
haic |
3 |
|
hamp |
3 |
|
health research |
3 |
|
hepatic tumorigenesis |
3 |
|
hepatobiliary diseases |
3 |
|
hepatocellular carcinoma (hcc) |
3 |
|
herb medicine |
3 |
|
herbal medicines |
3 |
|
huanglian jiedu decoction |
3 |
|
human cancers |
3 |
|
hyperuricemia |
3 |
|
hyperuricemic nephropathy |
3 |
|
immunity |
3 |
|
immunization |
3 |
|
immunotherapies |
3 |
|
immunotherapy |
3 |
|
inflammation-regulated cell death |
3 |
|
inhibitor of differentiation/dna binding 1 |
3 |
|
insulin resistance |
3 |
|
irinotecan |
3 |
|
leaky gut |
3 |
|
lianhua qingwen capsule |
3 |
|
library screening |
3 |
|
linc01056 |
3 |
|
lipid metabolism |
3 |
|
lipid modulation |
3 |
|
lipolysis |
3 |
|
liquid biopsy |
3 |
|
liver cancer |
3 |
|
liver function |
3 |
|
liver transplantation |
3 |
|
lncrnas |
3 |
|
local ablation |
3 |
|
long non-coding rna |
3 |
|
machine learning |
3 |
|
materia medica |
3 |
|
medical sciences |
3 |
|
melatonin |
3 |
|
meta-analysis |
3 |
|
metabolomics |
3 |
|
metastasis |
3 |
|
methylation |
3 |
|
micrornas |
3 |
|
microvesicle |
3 |
|
mind–body intervention |
3 |
|
mip1γ/ccr1 axis |
3 |
|
mir-23a |
3 |
|
mir-23a-3p |
3 |
|
monosodium urate crystal |
3 |
|
mulberry twig alkaloids |
3 |
|
multi-component chinese medicine formula |
3 |
|
multi-pathways |
3 |
|
multiple parallel hits |
3 |
|
muscle atrophy |
3 |
|
nafld |
3 |
|
natural compounds |
3 |
|
netosis |
3 |
|
network analysis |
3 |
|
network meta-analysis |
3 |
|
neutrophil extracellular traps |
3 |
|
new technologies |
3 |
|
non-coding rnas |
3 |
|
nonalcoholic fatty liver disease |
3 |
|
nonalcoholic steatohepatitis |
3 |
|
nsclc |
3 |
|
nutrition therapy |
3 |
|
pan-cancer |
3 |
|
pancreatic adenocarcinoma |
3 |
|
pard3 |
3 |
|
pattern recognition |
3 |
|
pd-1 |
3 |
|
phenolic acids |
3 |
|
physical exercise |
3 |
|
pns |
3 |
|
polysaccharides |
3 |
|
post-translational modification |
3 |
|
potassium oxonate |
3 |
|
pparα |
3 |
|
probiotics |
3 |
|
prognostic model |
3 |
|
proliferative diabetic retinopathy |
3 |
|
qigong |
3 |
|
rap1/cdc42 |
3 |
|
retina macrophages |
3 |
|
review |
3 |
|
safety |
3 |
|
saponins |
3 |
|
sars-cov-2 |
3 |
|
serological biomarkers |
3 |
|
sonic hedgehog |
3 |
|
sorafenib |
3 |
|
sorafenib resistance |
3 |
|
src |
3 |
|
steatosis |
3 |
|
subtypes |
3 |
|
sumoylation |
3 |
|
surgical resection |
3 |
|
systematic review |
3 |
|
tace |
3 |
|
tai chi |
3 |
|
tang-ning-tong-luo |
3 |
|
target identification |
3 |
|
targeted therapies |
3 |
|
therapeutic option |
3 |
|
tissue biopsy |
3 |
|
tumor |
3 |
|
tumor response |
3 |
|
tumor-associated neutrophils |
3 |
|
tumor-derived vesicles |
3 |
|
type i interferon |
3 |
|
tyrosine kinase inhibitor |
3 |
|
uric acid |
3 |
|
vasculature |
3 |
|
yoga |
3 |
|
acetylation |
2 |
|
adipogenesis |
2 |
|
age-related macular degeneration |
2 |
|
anti-cancer |
2 |
|
bibliometric analysis |
2 |
|
bibliometrics |
2 |
|
cancer-associated fibroblasts (cafs) |
2 |
|
cardiotoxicity |
2 |
|
ccs |
2 |
|
cell-cell communication |
2 |
|
chemotaxis |
2 |
|
chemotherapy |
2 |
|
chinese herbal formula |
2 |
|
chinese medicinal herb |
2 |
|
citespace |
2 |
|
computational machine analysis |
2 |
|
coptidis rhizoma |
2 |
|
cordyceps sinensis (berk) sacc |
2 |
|
covid-19 infection |
2 |
|
cs4 |
2 |
|
drug resistance |
2 |
|
drug resistance of hepatocellular carcinoma |
2 |
|
electroacupuncture |
2 |
|
genipin |
2 |
|
glial cells |
2 |
|
glycosylation |
2 |
|
hcc |
2 |
|
herbal plants |
2 |
|
in vivo crispr/cas9 screen |
2 |
|
long covid |
2 |
|
macrophage |
2 |
|
medicinal plants |
2 |
|
mir-3689a-3p |
2 |
|
modified covid-19 yorkshire rehabilitation scale (c19-yrsm) |
2 |
|
natural product |
2 |
|
osteoprotegerin |
2 |
|
parkinson’s disease |
2 |
|
pharmacological mechanisms |
2 |
|
post-covid-19 fatigue |
2 |
|
post-transcriptional modification |
2 |
|
postoperative recurrence |
2 |
|
pparɤ |
2 |
|
pparγ |
2 |
|
randomized trial |
2 |
|
retina-brain axis |
2 |
|
retinal pigment epithelial cells |
2 |
|
single-cell rna sequencing |
2 |
|
sirt1/p53 |
2 |
|
syne2 |
2 |
|
targeted therapy |
2 |
|
tumor microenvironment (tme) |
2 |
|
ubiquitination |
2 |
|
vosviewer |
2 |
|
weighted gene co-expression network analysis |
2 |
|
cdd-2103 |
1 |
|
chinese herbal formulation |
1 |
|
oxidative phosphorylation |
1 |
|
regulatory t cell |
1 |
|
tolerogenic dendritic cell |
1 |
|
ulcerative colitis |
1 |
